Connect with execs from Axios, The New York Times, Paramount and more.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
D+ Research: Marketers hesitate to adopt AI for influencer and CTV marketing
Advertisers embrace AI for social media and retail media marketing, but are slower to adopt AI for influencer and CTV marketing.
OpenAI set to expand ads to France, Germany and Ireland
The ads solutions vacancies in those markets signify that OpenAI will have achieved a presence in every major global advertising region within less than a year.
How Bandit Running is expanding internationally while staying hyperlocal
Bandit’s focus on core running communities has helped it grow enough to start expanding outward.